Developer docs
API playgroundTry for free, no card

Search company profiles

Dentroid

Full company profile

uuid0031g8b

Namestring
Dentroid
Legal namestring
Dentroid Pty Ltd
Websiteurl
dentroid.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Dentroid is an Australian medical device startup founded in 2017 by dentist Dr Omar Zuaiter and engineer Mr Alaa Habeb, developing a photonics- and robotics-based platform for pain-free dentistry. The company operates two core products: Nuralyte™, a needle-free photonic analgesia device that uses photobiomodulation to calm nociceptors and induce analgesia in under two minutes, and Dentroid-R, a femtosecond laser surgical device that ablates dental tissue via 'cold cutting' without needles, drills, intra-oral sprays, or thermal damage. Both technologies are integrated with miniaturised robotics and AI-assisted control, and the IP estate spans patents granted in 15 countries for Dentroid-R and an Australian grant plus second patent family for Nuralyte. The company is currently in pre-revenue clinical-trial stage, running a Stage 2 Nuralyte trial with 900+ patients across multiple Australian universities, with TGA and FDA regulatory verification still pending.

The business model is hardware sales of Nuralyte and Dentroid-R devices to dental practices and healthcare institutions, supplemented by licensing and co-commercialization revenue from a global partnership with Septodont (announced 5 June 2026). Go-to-market is enterprise field sales supported by clinical trial partnerships with the University of Queensland, Griffith University, and Australian National University, and global distribution leverage through Septodont's established dental pharmaceutical channels. Pricing is not publicly disclosed. Revenue to date has been limited to Australian government grants (Canberra Innovation Network pre-seed, ACT Government, AMGC, ARC, AEA), an oversubscribed 2018 seed round, and a $22.4M Septodont-linked round in June 2026. The company is headquartered in Canberra with an R&D facility in Queanbeyan, NSW, and operates with 11-50 employees.

Short descriptiontext

Dentroid is an Australian medical device startup developing Nuralyte™, a needle-free photonic analgesia device, and Dentroid-R, a femtosecond laser surgical platform, to deliver pain-free, drill-free dentistry to dental practitioners and needle-anxious patients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCanberra, Australia
HQ citystring
Canberra
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dental laser technology, photobiomodulation devices, needle-free analgesia, dental robotics, photonic dental equipment
Industry3 codes
PRIMARYHLABAAAB
Restorative General Dentistry (Fillings/Crowns/Bridges)
SECONDARYHLABAEAA
Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty)
SECONDARYHLABAFAA
Fixed Prosthodontics (Crowns, Bridges, Veneers)
Healthcare & Life Sciences/Dental Care Services/Prosthodontics & Restorative Specialty
NAICS code1 code
  • Dental Equipment and Supplies Manufacturing339114
SIC code2 codes
  • Dental Equipment & Supplies3843
  • Surgical & Medical Instruments & Apparatus3841
Product category
Dental Medical Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Nuralyte™ Device Sales
TypeHardware Sales
Description

Sale of the Nuralyte photonic analgesia device to dental practices and healthcare institutions. The device is designed for straightforward use in dental settings with no particular training required for dental staff. Technologies are still in development and pending regulatory verification by TGA and FDA.

dentroid.com
2Dentroid-R Device Sales
TypeHardware Sales
Description

Sale of the Dentroid-R femtosecond laser surgical device to dental practices. The device replaces traditional dental drills and rotary instruments, targeting premium dental care providers seeking pain-free treatment solutions.

dentroid.com
3Licensing and Commercialization (Septodont Partnership)
TypeLicensing Royalties
Description

Global development and commercialization partnership with Septodont (announced June 2026) for non-invasive pain management in dentistry, representing a licensing and co-commercialization revenue stream across international markets.

dentroid.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dentroid develops and manufactures photonic and robotic medical devices for pain-free dentistry. Its core products are Nuralyte™, a needle-free analgesia device that uses photobiomodulation (gentle bursts of proprietary light wavelengths to calm pain nerves), and Dentroid-R, a femtosecond laser surgical device that enables needle-, spray-, and drill-free dental treatment using 'cold cutting' technology. Both devices target dental practices seeking to replace traditional needles, drills, and intra-oral sprays.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Pre-emptive analgesia induced in human teeth in less than 2 minutes and lasting approximately 20 minutes after 60 seconds of Nuralyte™ light exposure
+3 more records
Product overview1 text field

Dentroid is developing a platform combining photonics and miniaturized robotics for pain-free dentistry, consisting of two main products: Nuralyte™ for needle-free pain management (analgesia/anesthesia using photobiomodulation) and Dentroid-R for precision dental treatment using femtosecond lasers. Together, these technologies aim to replace traditional needles, drills, and sprays with gentle light-based and robotic solutions.

Product and service2 records
1Nuralyte™
CategoryPhotonic Dental Analgesia Device
Description

A photonic analgesia device using photobiomodulation (PBM) with proprietary blends of light wavelengths to interact with mitochondria in pain nerves (nociceptors), inducing dental analgesia in under 2 minutes lasting approximately 20 minutes after 60 seconds of exposure. Designed to replace or reduce the need for traditional numbing needles in routine dental procedures for dental practices and practitioners.

2Dentroid-R
CategoryFemtosecond Laser Surgical Device
Description

A femtosecond laser-based robotic dental surgical device that enables needle-, intra-oral spray-, and drill-free dental treatment using patented 'cold cutting' technology to precisely ablate dental hard tissue without thermal damage or cooling sprays, leaving underlying tissue pristine for faster healing with fewer postoperative complications. Targets dental practices and premium dental care providers seeking pain-free treatment solutions.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-05
Description

Global development and commercialization partnership to pioneer non-invasive pain management in dentistry. Announced June 5, 2026 between Dentroid (Saint-Maur-des-Fossés, France and Canberra, Australia). Septodont is a major dental pharmaceutical company, making this a flagship partnership for international commercialization of Nuralyte™.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-12
Description

Collaborating on clinical trials for needle-free pain management technology. Joint press release (July 17, 2025) on new technology for accelerating healing and managing pain. Collaborators from Griffith include Prof Dzung Dao, Dr Peter Woodfield, Prof Roy George, and Dr Van Dau.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Conducting Stage 2 clinical trials for Nuralyte involving 900+ patients. UQ press release (May 28, 2025) announced 'Pain-free, needle-free dentistry under clinical trial'. Represents a core clinical validation and early commercial pathway partner.

4Australia's Economic Accelerator (AEA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Dentroid received the AEA Grant to support scaling of its technologies and progression toward commercialization.

dentroid.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Research collaboration to develop laser for cutting-edge robotic dentistry. IMCRC provided $100,000 in funding support for the Dentroid-R femtosecond laser dental robot development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-08-01
Description

Dentroid received a grant from AMGC in August 2020 to support the advancement of its advanced manufacturing capabilities for the dental laser technology.

7Canberra Innovation Network (CIN)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Dentroid won competitive pre-seed funding and acceleration from Canberra Innovation Network in May 2017. CIN is a foundational partner in Dentroid's early-stage development journey.

dentroid.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaborator on femtosecond laser dentistry and photonic technology development. Collaborators include Prof Andrei Rode, Prof Steve Madden, and Dr Ludovic Rapp. ANU fabrication capabilities used for device development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dentroid received an ARC Grant (Australian Research Council) in 2022. Also mentioned $28 million in ARC Linkage grants awarded across the sector, with Dentroid as a recipient.

10Platypus Medtech Consulting
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner providing medtech consulting services to support Dentroid's regulatory, clinical, and commercialization pathway planning.

dentroid.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1CAO Group
TypeEmerging player
Description

US dental and medical device manufacturer specializing in diode lasers and cosmetic/photonic dental products. Comparable as a smaller specialist targeting similar practice-level device adoption.

TypeBroad incumbent
Description

Family-owned US dental equipment manufacturer (chairs, delivery systems, lights). Broad incumbent serving the same dental practice customer base as Dentroid's device buyers.

TypeDirect peer
Description

Slovenian laser manufacturer (LightWalker, SkyPulse) used across dentistry, aesthetics, and surgery. Closely comparable to Dentroid's Er:YAG/femtosecond laser platform with overlapping dental applications.

TypeDirect peer
Description

Private US dental laser company behind Solea (CO2 9.3µm laser) — a needle- and drill-free platform sold to dental practices. Direct competitor to Dentroid-R with overlapping value proposition and target customer.

TypeDirect peer
Description

US-listed dental laser company (Waterlase, Epic) selling erbium and diode lasers to dental practices for hard/soft tissue procedures. Directly comparable to Dentroid-R as a dental laser device vendor targeting needle- and drill-free workflows.

TypeBroad incumbent
Description

Public medtech behind Invisalign and iTero scanners; a digital dentistry incumbent with comparable premium-practice positioning and technology-led disruption of traditional dental workflows.

TypeBroad incumbent
Description

Global dental implant and equipment leader serving premium dental practices. Comparable as a premium dental device incumbent with similar GTM to dental specialists.

8Dentsply Sirona
TypeBroad incumbent
Description

Largest dental equipment and consumables manufacturer globally (chairs, handpieces, CEREC CAD/CAM, imaging). Broad incumbent whose equipment Dentroid's photonic platform could complement or displace.

TypeDirect peer
Description

Manufacturer of the PerioLase Nd:YAG laser used in the LANAP protocol for periodontics. Comparable as a niche dental laser specialist targeting specific clinical indications.

TypeBroad incumbent
Description

Dental equipment and consumables parent company (Nobel Biocare, KaVo, Kerr). Broad incumbent with overlapping dental equipment portfolio and global distribution Dentroid could leverage or compete against.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dentroid

Dental Medical Equipmentdentroid.com

Dentroid is an Australian medical device startup developing Nuralyte™, a needle-free photonic analgesia device, and Dentroid-R, a femtosecond laser surgical platform, to deliver pain-free, drill-free dentistry to dental practitioners and needle-anxious patients globally.

What Dentroid does

Dentroid is an Australian medical device startup founded in 2017 by dentist Dr Omar Zuaiter and engineer Mr Alaa Habeb, developing a photonics- and robotics-based platform for pain-free dentistry. The company operates two core products: Nuralyte™, a needle-free photonic analgesia device that uses photobiomodulation to calm nociceptors and induce analgesia in under two minutes, and Dentroid-R, a femtosecond laser surgical device that ablates dental tissue via 'cold cutting' without needles, drills, intra-oral sprays, or thermal damage. Both technologies are integrated with miniaturised robotics and AI-assisted control, and the IP estate spans patents granted in 15 countries for Dentroid-R and an Australian grant plus second patent family for Nuralyte. The company is currently in pre-revenue clinical-trial stage, running a Stage 2 Nuralyte trial with 900+ patients across multiple Australian universities, with TGA and FDA regulatory verification still pending.

The business model is hardware sales of Nuralyte and Dentroid-R devices to dental practices and healthcare institutions, supplemented by licensing and co-commercialization revenue from a global partnership with Septodont (announced 5 June 2026). Go-to-market is enterprise field sales supported by clinical trial partnerships with the University of Queensland, Griffith University, and Australian National University, and global distribution leverage through Septodont's established dental pharmaceutical channels. Pricing is not publicly disclosed. Revenue to date has been limited to Australian government grants (Canberra Innovation Network pre-seed, ACT Government, AMGC, ARC, AEA), an oversubscribed 2018 seed round, and a $22.4M Septodont-linked round in June 2026. The company is headquartered in Canberra with an R&D facility in Queanbeyan, NSW, and operates with 11-50 employees.

Dentroid firmographics

Firmographics
Name
Dentroid
Legal name
Dentroid Pty Ltd
Website
https://dentroid.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Dentroid is an Australian medical device startup developing Nuralyte™, a needle-free photonic analgesia device, and Dentroid-R, a femtosecond laser surgical platform, to deliver pain-free, drill-free dentistry to dental practitioners and needle-anxious patients globally.
Ownership category
akta.pro rank

Dentroid industry classification

Industry
Product category
Dental Medical Equipment
NAICS
Dental Equipment and Supplies Manufacturing (339114)
SIC
Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLABAAAB
Restorative General Dentistry (Fillings/Crowns/Bridges)
SECONDARYHLABAEAA
Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty)
SECONDARYHLABAFAA
Fixed Prosthodontics (Crowns, Bridges, Veneers)
Healthcare & Life Sciences/Dental Care Services/Prosthodontics & Restorative Specialty

Keywords

  • Dental laser technology
  • Photobiomodulation devices
  • Needle-free analgesia
  • Dental robotics
  • Photonic dental equipment

Where Dentroid is headquartered

Location

Headquarters

HQ city
Canberra
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Dentroid business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Nuralyte™ Device Sales: Sale of the Nuralyte photonic analgesia device to dental practices and healthcare institutions. The device is designed for straightforward use in dental settings with no particular training required for dental staff. Technologies are still in development and pending regulatory verification by TGA and FDA.
  2. Dentroid-R Device Sales: Sale of the Dentroid-R femtosecond laser surgical device to dental practices. The device replaces traditional dental drills and rotary instruments, targeting premium dental care providers seeking pain-free treatment solutions.
  3. Licensing and Commercialization (Septodont Partnership): Global development and commercialization partnership with Septodont (announced June 2026) for non-invasive pain management in dentistry, representing a licensing and co-commercialization revenue stream across international markets.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Dentroid product offering

Product offering

Core offering

Dentroid develops and manufactures photonic and robotic medical devices for pain-free dentistry. Its core products are Nuralyte™, a needle-free analgesia device that uses photobiomodulation (gentle bursts of proprietary light wavelengths to calm pain nerves), and Dentroid-R, a femtosecond laser surgical device that enables needle-, spray-, and drill-free dental treatment using 'cold cutting' technology. Both devices target dental practices seeking to replace traditional needles, drills, and intra-oral sprays.

Product overview

Dentroid is developing a platform combining photonics and miniaturized robotics for pain-free dentistry, consisting of two main products: Nuralyte™ for needle-free pain management (analgesia/anesthesia using photobiomodulation) and Dentroid-R for precision dental treatment using femtosecond lasers. Together, these technologies aim to replace traditional needles, drills, and sprays with gentle light-based and robotic solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nuralyte™ A photonic analgesia device using photobiomodulation (PBM) with proprietary blends of light wavelengths to interact with mitochondria in pain nerves (nociceptors), inducing dental analgesia in under 2 minutes lasting approximately 20 minutes after 60 seconds of exposure. Designed to replace or reduce the need for traditional numbing needles in routine dental procedures for dental practices and practitioners.
  • Dentroid-R A femtosecond laser-based robotic dental surgical device that enables needle-, intra-oral spray-, and drill-free dental treatment using patented 'cold cutting' technology to precisely ablate dental hard tissue without thermal damage or cooling sprays, leaving underlying tissue pristine for faster healing with fewer postoperative complications. Targets dental practices and premium dental care providers seeking pain-free treatment solutions.

Quantifiable outcome

  • Pre-emptive analgesia induced in human teeth in less than 2 minutes and lasting approximately 20 minutes after 60 seconds of Nuralyte™ light exposure
  • +3 more outcomes

Companies that use Dentroid

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Dentroid technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Dentroid partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

  • SeptodontflagshipStrategic or Co-development Partner · 5 June 2026Global development and commercialization partnership to pioneer non-invasive pain management in dentistry. Announced June 5, 2026 between Dentroid (Saint-Maur-des-Fossés, France and Canberra, Australia). Septodont is a major dental pharmaceutical company, making this a flagship partnership for international commercialization of Nuralyte™.
  • Griffith UniversitycoreStrategic or Co-development Partner · 12 January 2024Collaborating on clinical trials for needle-free pain management technology. Joint press release (July 17, 2025) on new technology for accelerating healing and managing pain. Collaborators from Griffith include Prof Dzung Dao, Dr Peter Woodfield, Prof Roy George, and Dr Van Dau.
  • University of Queensland (UQ)coreStrategic or Co-development Partner · 1 January 2023Conducting Stage 2 clinical trials for Nuralyte involving 900+ patients. UQ press release (May 28, 2025) announced 'Pain-free, needle-free dentistry under clinical trial'. Represents a core clinical validation and early commercial pathway partner.
  • Australia's Economic Accelerator (AEA)coreStrategic or Co-development Partner · 1 January 2023Dentroid received the AEA Grant to support scaling of its technologies and progression toward commercialization.
  • IMCRC (Innovative Manufacturing Cooperative Research Centre)coreStrategic or Co-development Partner · 1 January 2022Research collaboration to develop laser for cutting-edge robotic dentistry. IMCRC provided $100,000 in funding support for the Dentroid-R femtosecond laser dental robot development.
  • AMGC (Advanced Manufacturing Growth Centre)coreStrategic or Co-development Partner · 1 August 2020Dentroid received a grant from AMGC in August 2020 to support the advancement of its advanced manufacturing capabilities for the dental laser technology.
  • Canberra Innovation Network (CIN)coreStrategic or Co-development Partner · 1 January 2017Dentroid won competitive pre-seed funding and acceleration from Canberra Innovation Network in May 2017. CIN is a foundational partner in Dentroid's early-stage development journey.
  • Australian National University (ANU)coreStrategic or Co-development PartnerResearch collaborator on femtosecond laser dentistry and photonic technology development. Collaborators include Prof Andrei Rode, Prof Steve Madden, and Dr Ludovic Rapp. ANU fabrication capabilities used for device development.
  • ARC (Australian Research Council)coreStrategic or Co-development PartnerDentroid received an ARC Grant (Australian Research Council) in 2022. Also mentioned $28 million in ARC Linkage grants awarded across the sector, with Dentroid as a recipient.
  • Platypus Medtech ConsultingminorStrategic or Co-development PartnerPartner providing medtech consulting services to support Dentroid's regulatory, clinical, and commercialization pathway planning.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Dentroid competitors and assessment

Company assessment

Emerging players

  • CAO Group: US dental and medical device manufacturer specializing in diode lasers and cosmetic/photonic dental products. Comparable as a smaller specialist targeting similar practice-level device adoption.

Broad incumbents

  • A-dec: Family-owned US dental equipment manufacturer (chairs, delivery systems, lights). Broad incumbent serving the same dental practice customer base as Dentroid's device buyers.
  • Align Technology: Public medtech behind Invisalign and iTero scanners; a digital dentistry incumbent with comparable premium-practice positioning and technology-led disruption of traditional dental workflows.
  • Straumann Group: Global dental implant and equipment leader serving premium dental practices. Comparable as a premium dental device incumbent with similar GTM to dental specialists.
  • Dentsply Sirona: Largest dental equipment and consumables manufacturer globally (chairs, handpieces, CEREC CAD/CAM, imaging). Broad incumbent whose equipment Dentroid's photonic platform could complement or displace.
  • Envista Holdings: Dental equipment and consumables parent company (Nobel Biocare, KaVo, Kerr). Broad incumbent with overlapping dental equipment portfolio and global distribution Dentroid could leverage or compete against.

Direct peers

  • Fotona: Slovenian laser manufacturer (LightWalker, SkyPulse) used across dentistry, aesthetics, and surgery. Closely comparable to Dentroid's Er:YAG/femtosecond laser platform with overlapping dental applications.
  • Convergent Dental: Private US dental laser company behind Solea (CO2 9.3µm laser) — a needle- and drill-free platform sold to dental practices. Direct competitor to Dentroid-R with overlapping value proposition and target customer.
  • Biolase: US-listed dental laser company (Waterlase, Epic) selling erbium and diode lasers to dental practices for hard/soft tissue procedures. Directly comparable to Dentroid-R as a dental laser device vendor targeting needle- and drill-free workflows.
  • Millennium Dental Technologies: Manufacturer of the PerioLase Nd:YAG laser used in the LANAP protocol for periodontics. Comparable as a niche dental laser specialist targeting specific clinical indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Dentroid social profiles

Digital presence

Dentroid financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dentroid leadership team

Management profile

Number of profiles

Profiles6 records

Dentroid funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dentroid M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dentroid

What does Dentroid do?

Dentroid develops and manufactures photonic and robotic medical devices for pain-free dentistry. Its core products are Nuralyte™, a needle-free analgesia device that uses photobiomodulation (gentle bursts of proprietary light wavelengths to calm pain nerves), and Dentroid-R, a femtosecond laser surgical device that enables needle-, spray-, and drill-free dental treatment using 'cold cutting' technology. Both devices target dental practices seeking to replace traditional needles, drills, and intra-oral sprays.

Is Dentroid a public or private company?

Dentroid is a private company. It is classified as venture growth investor backed and is currently operating.

When was Dentroid founded?

Dentroid was founded in 2017. It employs 1 to 10 people.

Where is Dentroid based?

Dentroid is headquartered in Canberra, Australia, in the Oceania region.

How does Dentroid make money?

Three revenue lines are on record. Nuralyte™ Device Sales are the primary driver. The others are dentroid-R Device Sales and licensing and Commercialization (Septodont Partnership).

Who are Dentroid's main competitors?

CAO Group is listed as an emerging player. Broad incumbents are A-dec, Align Technology, Straumann Group, Dentsply Sirona and Envista Holdings. Direct peers are Fotona, Convergent Dental, Biolase and Millennium Dental Technologies.

Does Dentroid have an API?

No public API is recorded for Dentroid.

What industry is Dentroid in?

Dentroid's product category is Dental Medical Equipment. Its primary akta.pro industry code is HLABAAAB, Restorative General Dentistry (Fillings/Crowns/Bridges), with a secondary code of HLABAEAA, Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty). Its NAICS code is 339114 and its SIC code is 3843.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals